These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20113178)

  • 1. Pneumococcal vaccination and revaccination in the elderly population.
    Nichol KL
    J Infect Dis; 2010 Mar; 201(5):659-61. PubMed ID: 20113178
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil.
    Brandão AP; de Oliveira TC; de Cunto Brandileone MC; Gonçalves JE; Yara TI; Simonsen V
    Vaccine; 2004 Dec; 23(6):762-8. PubMed ID: 15542200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Splenectomy and pneumococcal vaccination].
    Jeurissen A
    Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1142-3; author reply 1143. PubMed ID: 12822528
    [No Abstract]   [Full Text] [Related]  

  • 4. Giving pneumococcal vaccine to mothers.
    Shann F
    Vaccine; 2007 Aug; 25(33):6147. PubMed ID: 17600595
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological responses to pneumococcal vaccine in frail older people.
    Ridda I; Macintyre CR; Lindley R; Gao Z; Sullivan JS; Yuan FF; McIntyre PB
    Vaccine; 2009 Mar; 27(10):1628-36. PubMed ID: 19100304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.
    Moore QC; Bosarge JR; Quin LR; McDaniel LS
    Vaccine; 2006 Jul; 24(29-30):5755-61. PubMed ID: 16759765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
    Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
    J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
    Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR
    Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with pneumococcal immunisation among hospitalised elderly persons: a survey of patient's perception, attitude, and knowledge.
    Ridda I; Motbey C; Lam L; Lindley IR; McIntyre PB; Macintyre CR
    Vaccine; 2008 Jan; 26(2):234-40. PubMed ID: 18054818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Declining invasive pneumococcal disease in the U.S. elderly.
    McBean AM; Park YT; Caldwell D; Yu X
    Vaccine; 2005 Dec; 23(48-49):5641-5. PubMed ID: 16111788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases.
    Cherif H; Landgren O; Konradsen HB; Kalin M; Björkholm M
    Vaccine; 2006 Jan; 24(1):75-81. PubMed ID: 16107293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of pneumococcal vaccine in heart transplant recipients.
    Blumberg EA; Brozena SC; Stutman P; Wood D; Phan HM; Musher DM
    Clin Infect Dis; 2001 Jan; 32(2):307-10. PubMed ID: 11170924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention with power. Breaking through barriers to pneumococcal vaccination.
    Miller T; Bishop J; Ruess L
    Adv Nurse Pract; 2008 Sep; 16(9):61-3. PubMed ID: 19999035
    [No Abstract]   [Full Text] [Related]  

  • 14. Opsonic function of bronchoalveolar lavage IgG after pneumococcal vaccination in HIV-infected and uninfected adults.
    Tam JC; Grant NL; Freire-Moran L; Tolmie H; French N; Gordon SB
    J Allergy Clin Immunol; 2009 Jun; 123(6):1420-1. PubMed ID: 19423153
    [No Abstract]   [Full Text] [Related]  

  • 15. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine.
    Long SS
    Clin Infect Dis; 2005 Jul; 41(1):30-4. PubMed ID: 15937759
    [No Abstract]   [Full Text] [Related]  

  • 16. Pneumococcal vaccination of adults: polysaccharide or conjugate.
    Med Lett Drugs Ther; 2009 Jun; 51(1314):47-8. PubMed ID: 19528887
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
    Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What do the next 100 years hold for pneumococcal vaccination?
    Rijkers GT; van Mens SP; van Velzen-Blad H
    Expert Rev Vaccines; 2010 Nov; 9(11):1241-4. PubMed ID: 21087102
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dutch Health Council advice 'Vaccination against pneumococcal infections in elderly persons and immunocompromised adults'].
    Kullberg BJ
    Ned Tijdschr Geneeskd; 2004 May; 148(18):871-4. PubMed ID: 15152387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a large-scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden.
    Spindler C; Hedlund J; Jasir A; Normark BH; Ortqvist A
    Vaccine; 2008 Oct; 26(43):5541-6. PubMed ID: 18602961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.